Bio-Path Holdings, Inc.

Bio-Path Holdings, Inc.verified

BPTH

Price:

$2.11

Market Cap:

$4.39M

Bio-Path Holdings, Inc. operates as a clinical and preclinical stage oncology focused RNAi nano particle drug development company in the United States. The company develops products based on DNAbilize, a drug delivery and antisense technology that uses P-ethoxy, which is a deoxyribonucleic acid (DNA) backbone modification intended to protect the DNA from destruction. Its lead drug candidate is prexigebersen, which is in Phase II clinical trials for the treatment of acute myeloid leukemia (AML) and myelodysplastic syndrome. It is also developing Liposomal Bcl-2 for the treatment of refractory/relapsed lymphoma and chronic lymphocytic leukemia; Liposomal STAT3 that is in preclinical stage for ...[Read more]

Industry

Biotechnology

IPO Date

2008-03-04

Stock Exchange

NASDAQ

Ticker

BPTH

The PE Ratio as of June 2024 (TTM) for Bio-Path Holdings, Inc. (BPTH) is -0.08

According to Bio-Path Holdings, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -0.08. This represents a change of -82.10% compared to the average of -0.45 of the last 4 quarters.

Bio-Path Holdings, Inc. (BPTH) Historical PE Ratio (quarterly & annually)

How has BPTH PE Ratio performed in the past?

The mean historical PE Ratio of Bio-Path Holdings, Inc. over the last ten years is -190.24. The current -0.08 PE Ratio has changed -95.79% with respect to the historical average. Over the past ten years (40 quarters), BPTH's PE Ratio was at its highest in in the March 2024 quarter at -0.24. The PE Ratio was at its lowest in in the June 2014 quarter at -1072.59.

Quarterly (TTM)
Annual

Average

-190.24

Median

-3.68

Minimum

-1050.85

Maximum

-0.28

Bio-Path Holdings, Inc. (BPTH) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Bio-Path Holdings, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 95.86%

Maximum Annual PE Ratio = -0.28

Minimum Annual Increase = -91.62%

Minimum Annual PE Ratio = -1050.85

Quarterly (TTM)
Annual
YearPE RatioChange
2023-0.28-65.33%
2022-0.79-67.31%
2021-2.4395.86%
2020-1.24-50.31%
2019-2.50-48.73%
2018-4.87-91.62%
2017-58.13-84.32%
2016-370.80-9.67%
2015-410.49-60.94%
2014-1050.85-39.89%

Bio-Path Holdings, Inc. (BPTH) Average PE Ratio

How has BPTH PE Ratio performed in the past?

The current PE Ratio of Bio-Path Holdings, Inc. (BPTH) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

-1.17

5-year avg

-1.45

10-year avg

-190.24

Bio-Path Holdings, Inc. (BPTH) PE Ratio vs. Peers

How is BPTH’s PE Ratio compared to its peers?

Bio-Path Holdings, Inc.’s PE Ratio is greater than Catalyst Biosciences, Inc. (-0.44), less than Diffusion Pharmaceuticals Inc. (-0.00), greater than Capricor Therapeutics, Inc. (-6.06), greater than NextCure, Inc. (-0.71), greater than Pulmatrix, Inc. (-0.82), less than Bellerophon Therapeutics, Inc. (-0.06), greater than Crinetics Pharmaceuticals, Inc. (-13.99), greater than Applied Molecular Transport Inc. (-0.14), greater than Aileron Therapeutics, Inc. (-1.44), greater than Benitec Biopharma Inc. (-0.83), greater than Onconova Therapeutics, Inc. (-1.15), greater than Moleculin Biotech, Inc. (-0.34), greater than Achieve Life Sciences, Inc. (-4.56), greater than Icosavax, Inc. (-8.27), greater than Akari Therapeutics, Plc (-1.60),

Build a custom stock screener for Bio-Path Holdings, Inc. (BPTH) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Bio-Path Holdings, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Bio-Path Holdings, Inc. (BPTH) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Bio-Path Holdings, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the PE Ratio?

How can you use the PE Ratio?

What is Bio-Path Holdings, Inc.'s PE Ratio?

How is the PE Ratio calculated for Bio-Path Holdings, Inc. (BPTH)?

What is the highest PE Ratio for Bio-Path Holdings, Inc. (BPTH)?

What is the 3-year average PE Ratio for Bio-Path Holdings, Inc. (BPTH)?

What is the 5-year average PE Ratio for Bio-Path Holdings, Inc. (BPTH)?

How does the current PE Ratio for Bio-Path Holdings, Inc. (BPTH) compare to its historical average?